Rivaroxaban Granule 70748-0355

Product NDC

70748-0355

Manufacturer: Lupin Pharmaceuticals, Inc.
Dosage Form: For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: September 29, 2025
Listing Expires: December 31, 2027
Application: ANDA218195

Need to source Rivaroxaban Granule? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Rivaroxaban	155 mg/1

Drug Class

Factor Xa Inhibitor [EPC]Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]

Packaging Options(1)

70748-0355-01

1 BOTTLE in 1 CARTON (70748-355-01) / 1 FOR SUSPENSION in 1 BOTTLE

View →